Clinical Trials Directory

Trials / Unknown

UnknownNCT03466931

Efficacy of the "Milk Ladder" Intervention in the Development of Tolerance and the Recognition of B Cell Epitopes in Babies Who Are Allergic to Cow's Milk Proteins

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
Hospital San Carlos, Madrid · Academic / Other
Sex
All
Age
1 Month – 12 Months
Healthy volunteers
Not accepted

Summary

Food allergies have become a relevant health problem in westernized societies, particularly, with children. Cow's milk (CM), along with hen's eggs, are the most common foods eliciting allergic reactions in children under 4 years of age. The main objective of this intervention study is to evaluate the safety and efficacy of the intervention known as "The Milk Ladder" in the development of tolerance by children with CM allergies. This will be compared to an historical cohort (CoALE), which investigated the natural history of this allergy. Additionally, the ability of informative epitopes will be evaluated for their potential to predict tolerance and their correlation against clinical variables. The "Milk Ladder" will be evaluated within a prospective cohort of CM allergic children. This intervention is enacted through the introduction of meals cooked with progressively increasing amounts of cow's milk into the participant's diet. The primary outcome will be the development of tolerance which will be evaluated through a double-blind placebo-controlled food challenge. IgE and IgG4 epitopes will be described using a peptide microarray immunoassay. Quality of life will be determined by administering the FAQLQ-PF disease-specific questionnaire. Finally, within a subgroup of study participants, the ability of different peptides to activate basophils will be analyzed, and CM T cell epitopes will be studied by means of T-cell proliferation and cytokine production assays.

Conditions

Interventions

TypeNameDescription
OTHERMilkMeals containing Milk and Milk

Timeline

Start date
2018-06-01
Primary completion
2021-06-01
Completion
2021-08-30
First posted
2018-03-15
Last updated
2020-06-26

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03466931. Inclusion in this directory is not an endorsement.